WTB
PTCT icon

Washington Trust Bank’s PTC Therapeutics PTCT Stock Holding History

Washington Trust Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100
Closed -$1K – 853
2016
Q1 		$1K Hold
100
– – ﹤0.01% 748
2015
Q4 		$3K Buy
+100
New +$2.94K ﹤0.01% 685

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Washington Trust Bank's PTCT Position: Q2 2016 in Review

Washington Trust Bank sold out of PTC Therapeutics (PTCT) in Q2 2016, closing a stake of 100 shares — an estimated $1K sold.

Washington Trust Bank first reported a position in PTCT in Q4 2015 and held it in 2 quarters. The position peaked at $3K in Q4 2015. 118 funds tracked by Wall St. Rank hold PTCT as of Q2 2016.

  • Washington Trust Bank reported no remaining PTC Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Washington Trust Bank sold 100 PTC Therapeutics shares in Q2 2016, an estimated $1K.
  • Washington Trust Bank first reported a position in PTC Therapeutics in Q4 2015 and held it in 2 quarters.
  • Washington Trust Bank's PTC Therapeutics position peaked at $3K in Q4 2015.
  • 118 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2016.

Based on Washington Trust Bank's 13F filing for Q2 2016, filed 7 Jul 2016.